GIA
RMD icon

Gladstone Institutional Advisory’s ResMed RMD Stock Holding History

Gladstone Institutional Advisory’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-973
Closed -$256K – 627
2021
Q3 		$256K Buy
+973
New +$266K 0.03% 463

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Gladstone Institutional Advisory's RMD Position: Q4 2021 in Review

Gladstone Institutional Advisory sold out of ResMed (RMD) in Q4 2021, closing a stake of 973 shares — an estimated $256K sold.

Gladstone Institutional Advisory first reported a position in RMD in Q3 2021 and held it in 1 quarter. The position peaked at $256K in Q3 2021. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

  • Gladstone Institutional Advisory reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 973 ResMed shares in Q4 2021, an estimated $256K.
  • Gladstone Institutional Advisory first reported a position in ResMed in Q3 2021 and held it in 1 quarter.
  • Gladstone Institutional Advisory's ResMed position peaked at $256K in Q3 2021.
  • 723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2021, filed 11 Feb 2022.